"Naltrexone"[nm] - Search Results

Year	Number of Results
1974	1
1975	25
1976	76
1977	28
1978	57
1979	63
1980	62
1981	88
1982	95
1983	97
1984	125
1985	136
1986	138
1987	140
1988	144
1989	176
1990	179
1991	165
1992	172
1993	248
1994	211
1995	201
1996	197
1997	227
1998	208
1999	233
2000	254
2001	212
2002	181
2003	217
2004	195
2005	229
2006	244
2007	260
2008	299
2009	266
2010	246
2011	260
2012	236
2013	293
2014	282
2015	270
2016	253
2017	252
2018	278
2019	274
2020	295
2021	272
2022	235
2023	166
2024	98

1

Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.

Grilo CM, Lydecker JA, Fineberg SK, Moreno JO, Ivezaj V, Gueorguieva R. Grilo CM, et al. Am J Psychiatry. 2022 Dec 1;179(12):927-937. doi: 10.1176/appi.ajp.20220267. Epub 2022 Oct 26. Am J Psychiatry. 2022. PMID: 36285406 Free PMC article. Clinical Trial.

2

Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.

McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, Coffey CP, Edlund MD, Bobashev G, Jonas DE. McPheeters M, et al. JAMA. 2023 Nov 7;330(17):1653-1665. doi: 10.1001/jama.2023.19761. JAMA. 2023. PMID: 37934220 Free PMC article.

3

Naltrexone and Alcohol Use.

Avery J. Avery J. Am J Psychiatry. 2022 Dec 1;179(12):886-887. doi: 10.1176/appi.ajp.20220821. Am J Psychiatry. 2022. PMID: 36453035 No abstract available.

4

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19.

Bonilla H, Tian L, Marconi VC, Shafer R, McComsey GA, Miglis M, Yang P, Bonilla A, Eggert L, Geng LN. Bonilla H, et al. Int Immunopharmacol. 2023 Nov;124(Pt B):110966. doi: 10.1016/j.intimp.2023.110966. Epub 2023 Oct 5. Int Immunopharmacol. 2023. PMID: 37804660 Free PMC article.

5

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. Burnette EM, et al. Drugs. 2022 Feb;82(3):251-274. doi: 10.1007/s40265-021-01670-3. Epub 2022 Feb 8. Drugs. 2022. PMID: 35133639 Free PMC article. Review.

6

AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity.

Grunvald E, Shah R, Hernaez R, Chandar AK, Pickett-Blakely O, Teigen LM, Harindhanavudhi T, Sultan S, Singh S, Davitkov P; AGA Clinical Guidelines Committee. Grunvald E, et al. Gastroenterology. 2022 Nov;163(5):1198-1225. doi: 10.1053/j.gastro.2022.08.045. Epub 2022 Oct 20. Gastroenterology. 2022. PMID: 36273831

7

Overview of Alcohol Use Disorder.

Kranzler HR. Kranzler HR. Am J Psychiatry. 2023 Aug 1;180(8):565-572. doi: 10.1176/appi.ajp.20230488. Am J Psychiatry. 2023. PMID: 37525595 Review.

8

Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial.

Grilo CM, Lydecker JA, Jastreboff AM, Pittman B, McKee SA. Grilo CM, et al. Obesity (Silver Spring). 2023 Nov;31(11):2762-2773. doi: 10.1002/oby.23898. Epub 2023 Sep 26. Obesity (Silver Spring). 2023. PMID: 37751990 Clinical Trial.

9

Is low-dose naltrexone effective in chronic pain management?

Radi R, Huang H, Rivera J, Lyon C, DeSanto K. Radi R, et al. J Fam Pract. 2023 Sep;72(7):320-321. doi: 10.12788/jfp.0654. J Fam Pract. 2023. PMID: 37729143 Clinical Trial.

10

The Utilization of Low Dose Naltrexone for Chronic Pain.

Poliwoda S, Noss B, Truong GTD, Creech ZA, Koushik SS, Urits I, Viswanath O. Poliwoda S, et al. CNS Drugs. 2023 Aug;37(8):663-670. doi: 10.1007/s40263-023-01018-3. Epub 2023 Jul 28. CNS Drugs. 2023. PMID: 37505425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8,813 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8,813 results

Results by year